Kazemi, F., Gendreau, J. L., Parker, M., Chakravarti, S., Jimenez, A. E., Ahmed, A. K., Rincon-Torroella, J., Jackson, C., Gallia, G. L., Bettegowda, C., Weingart, J., Brem, H., & Mukherjee, D. (2025). Creating a predictive model and online calculator for high-value care outcomes following glioblastoma resection: incorporating neighborhood socioeconomic status index. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-024-04927-5

Mandelberg, N., Hodges, T. R., Wang, T. J. C., McGranahan, T., Olson, J. J., & Orringer, D. A. (2025). Congress of Neurological Surgeons systematic review and evidence based guideline on neuropathology for WHO grade II diffuse glioma: update. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-024-04898-7

Mrugala, M. M., Shi, W., Iwomoto, F., Lukas, R. V., Palmer, J. D., Suh, J. H., & Glas, M. (2024). Global post‑marketing safety surveillance of Tumor Treating Fields (TTFields) therapy in over 25,000 patients with CNS malignancies treated between 2011–2022. Journal of Neuro-Oncology, 169(1), 25–38. https://doi.org/10.1007/s11060-024-04682-7

Kinslow, C. J., Siegelin, M. D., Iwamoto, F. M., Gallitto, M., Neugut, A. I., Yu, J. B., Cheng, S. K., & Wang, T. J. C. (2023). MGMT promoter methylation in 1p19q-intact gliomas. Journal of Neuro-Oncology, 166(1), 73–78. https://doi.org/10.1007/s11060-023-04515-z

Bunevicius, A., Donovan, L., & Sheehan, J. (2022). Health related quality of life trajectories after stereotactic radiosurgery for brain metastases: a systematic review. Journal of Neuro-Oncology, 159(2), 319–331. https://doi.org/10.1007/s11060-022-04067-8